Search Results - "Kemp, Stephen F"

Refine Results
  1. 1

    Adrenal Insufficiency: Still a Cause of Morbidity and Death in Childhood by Shulman, Dorothy I, Palmert, Mark R, Kemp, Stephen F, Lawson Wilkins Drug and Therapeutics Committee

    Published in Pediatrics (Evanston) (01-02-2007)
    “…Adrenal insufficiency is relatively rare in childhood and adolescence. Signs and symptoms may be nonspecific; therefore, the diagnosis may not be suspected…”
    Get full text
    Journal Article
  2. 2

    Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues by Thrailkill, Kathryn M, Lumpkin, Jr, Charles K, Bunn, R Clay, Kemp, Stephen F, Fowlkes, John L

    “…Diabetic osteoporosis is increasingly recognized as a significant comorbidity of type 1 diabetes mellitus. In contrast, type 2 diabetes mellitus is more…”
    Get more information
    Journal Article
  3. 3

    Subcutaneous Immunoglobulin (SCIG) Therapy during Pregnancy in a Woman with Hyper-IgM (HIGM) Syndrome by Olmsted, Blake R., MD, Kemp, Stephen F., MD, FAAAAI

    Published in Journal of allergy and clinical immunology (01-02-2017)
    “…Patients with immunodeficiency require special consideration of immunoglobulin replacement strategies during pregnancy, and IgG trough levels decrease during…”
    Get full text
    Journal Article
  4. 4

    Pediatric Allergic Rhinitis by Tharpe, Chet A., MD, Kemp, Stephen F., MD

    “…Allergic rhinitis is a common pediatric problem with significant comorbidities and potential complications. This article is an overview of the epidemiology,…”
    Get full text
    Journal Article
  5. 5

    Matrix Metalloproteinase-2 Dysregulation in Type 1 Diabetes by Thrailkill, Kathryn M, Bunn, Robert C, Moreau, Cynthia S, Cockrell, Gael E, Simpson, Pippa M, Coleman, Hannah N, Frindik, J. Paul, Kemp, Stephen F, Fowlkes, John L

    Published in Diabetes care (01-09-2007)
    “…OBJECTIVE:--Dysregulation of matrix metalloproteinase (MMP)-2 may contribute pathologically to the development of diabetes complications, including diabetic…”
    Get full text
    Journal Article
  6. 6

    Recognition, Treatment, and Prevention of Anaphylaxis by Moore, Lindsey E., DO, Kemp, Ann M., RPh, MD, Kemp, Stephen F., MD

    “…Anaphylaxis is an acute and potentially lethal multisystem allergic reaction that occurs in a variety of clinical scenarios and is almost unavoidable…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Growth and Growth Hormone Treatment in Children with Chronic Diseases by Pozzo, Alba Morales, MD, Kemp, Stephen F., MD, PhD

    “…Growth hormone has been available for treatment of various conditions for over 50 years. There have been a number of chronic disease states in which it has…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Office Approach to Anaphylaxis: Sooner Better than Later by Kemp, Stephen F., MD

    Published in The American journal of medicine (01-08-2007)
    “…Abstract Anaphylaxis, an acute and potentially lethal multisystem allergic reaction, is almost unavoidable in medical practice. Physicians must be able to…”
    Get full text
    Journal Article
  12. 12

    Anaphylaxis: Office Management and Prevention by Oswalt, Matthew L., MD, Kemp, Stephen F., MD

    “…Anaphylaxis, an acute and potentially lethal multisystem allergic reaction, is almost unavoidable in medical practice. Health care professionals must be able…”
    Get full text
    Journal Article
  13. 13

    Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization by Kemp, Stephen F, Lockey, Richard F, Simons, F Estelle R

    Published in The World Allergy Organization journal (01-07-2008)
    “…Anaphylaxis is an acute and potentially lethal multisystem allergic reaction. Most consensus guidelines for the past 30 years have held that epinephrine is the…”
    Get full text
    Journal Article
  14. 14

    Pathophysiology of anaphylaxis by Khan, Bilal Q, Kemp, Stephen F

    “…PURPOSE OF REVIEWThis review aims to provide an overview of the evolving understanding of the pathophysiology of anaphylaxis. RECENT FINDINGSImmunopathologic…”
    Get full text
    Journal Article
  15. 15

    Anaphylaxis: A review of causes and mechanisms by Kemp, Stephen F., Lockey, Richard F.

    Published in Journal of allergy and clinical immunology (01-09-2002)
    “…Anaphylaxis is a life-threatening syndrome resulting from the sudden release of mast cell- and basophil-derived mediators into the circulation. Foods and…”
    Get full text
    Journal Article
  16. 16

    Managing idiopathic short stature : role of somatropin (rDNA origin) for injection by Frindik, J. Paul, Kemp, Stephen F

    Published in Biologics (24-06-2010)
    “…Overviews the history and efficacy of growth hormone (GH) treatment for children with idiopathic short stature (ISS). Discusses safety and psychosocial…”
    Get full text
    Journal Article
  17. 17

    Pharmacotherapy in refractory anaphylaxis: when intramuscular epinephrine fails by Kemp, Ann M, Kemp, Stephen F

    “…PURPOSE OF REVIEWThis review aims to provide an evidence-based overview of several pharmacotherapeutic options available for refractory anaphylaxis when…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The post-anaphylaxis dilemma: How long is long enough to observe a patient after resolution of symptoms? by Kemp, Stephen F.

    Published in Current allergy and asthma reports (01-03-2008)
    “…Anaphylaxis may recur 1 to 72 hours after initial signs and symptoms apparently resolve. Reported incidence of biphasic anaphylaxis varies from 1% to 23%…”
    Get full text
    Journal Article
  20. 20

    Insulin-Like Growth Factor-I Deficiency in Children with Growth Hormone Insensitivity: Current and Future Treatment Options by Kemp, Stephen F.

    “…Growth hormone (GH) acts directly at the growth plate and through the production of insulin-like growth factor (IGF)-I. At least 50% of the hormone circulates…”
    Get full text
    Journal Article